HuagongsheHuagongshe Chemistry Print Report · For research reference only
3-(6-fluorobenzothiazol-2-yl)-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine → HCID 67521036, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 3-(6-fluorobenzothiazol-2-yl)-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine | HCID 67521015 | — |
| Reactant | HCID 67521227 | HCID 67521227 | — |
| Product | HCID 67521036 | HCID 67521036 | — |
Reaction Steps
Same procedure as 3-(6-fluorobenzothiazol-2-yl)-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine except using 5-bromo-2-iodo-1,3-benzothiazole in place of 2-chloro-6-fluorobenzothiazole to afford the title compound as a yellow solid. 1H NMR (400 MHz, DMSO-d6): δ=2.11-2.30 (m, 4H), 3.11 (q, J=11.0 Hz, 2H), 3.41 (d, J=12.8 Hz, 2H), 4.47-4.56 (m, 1H), 7.74 (dd, J=8.6, 2.0 Hz, 1H), 8.03-8.08 (m, 2H), 8.34 (br. s., 1H), 8.39 (s, 1H), 8.51 (d, J=1.4 Hz, 1H), 8.54 (d, J=2.2 Hz, 1H). MS (ES+): m/z=455.02/457.00 [MH+]. HPLC: tR=2.19 min (ZQ2, polar—5 min).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08178668B2 |
| Source dataset | uspto-grants-2012_05 |
| ORD ID | ord-3cc0da3730df4ed2afd2e3255f295f95 |
| Source note | uspto-grants-2012_05 |